GP
ELV icon

Geneva Partners’s Elevance Health ELV Stock Holding History

Geneva Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,310
Closed -$2.44M – 78
2023
Q1 		$2.44M Sell
5,310
-4,484
-46% -$2.13M 2.09% 20
2022
Q4 		$5.02M Sell
9,794
-360
-4% -$183K 4.74% 5
2022
Q3 		$4.61M Sell
10,154
-508
-5% -$243K 5.27% 3
2022
Q2 		$5.14M Sell
10,662
-1,187
-10% -$587K 5.06% 3
2022
Q1 		$5.82M Buy
+11,849
New +$5.42M 3.6% 6

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geneva Partners's ELV Position: Q2 2023 in Review

Geneva Partners sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 5,310 shares — an estimated $2.44M sold.

Geneva Partners first reported a position in ELV in Q1 2022 and held it in 5 quarters. The position peaked at $5.82M in Q1 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Geneva Partners reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Geneva Partners sold 5,310 Elevance Health shares in Q2 2023, an estimated $2.44M.
  • Geneva Partners first reported a position in Elevance Health in Q1 2022 and held it in 5 quarters.
  • Geneva Partners's Elevance Health position peaked at $5.82M in Q1 2022.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Geneva Partners's 13F filing for Q2 2023, filed 3 Aug 2023.